Navigation Links
Anthrax Vaccine Immunization Program


The Anthrax Vaccine Immunization Program (AVIP), is the name of the policy set forth by the United States government to immunize its military and specific civilian personnel with the anthrax vaccine. It began in earnest in 1997 by the Clinton administration. Thereafter it ran into a few FDA and judicial obstacles (mainly concerning the methods and viability of the vaccine manufactured by BioPort, a subsidiary of Emergent BioSolutions Inc.).

Senior Chief Petty Officer John Payhurst administers the first in a series of anthrax vaccinations to one of 6,200 sailors aboard the aircraft carrier USS John C. Stennis (CVN 74) on March 17, 1998. Stennis and its embarked Carrier Air Wing 7 are on station in the Persian Gulf in support of Operation Southern Watch, which is the U.S. and coalition enforcement of the no-fly-zone over Southern Iraq. Payhurst, from Virginia Beach, Va., is a Navy hospital corpsmen. The Stennis is homeported in Norfolk, Va. DoD photo by Petty Officer 3rd Class Mike Larson, U.S. Navy.

Contents

History

In 1998, the Clinton administration required the inoculation of all military members[2][3], despite the fact that the Food and Drug Administration (FDA) issued a warning letter to the anthrax vaccine manufacturer threatening to revoke its product licenses unless immediate action was taken to correct deficiencies on March 11, 1997.[4] In June 2001, the DOD halted vaccination due to non-FDA approved changes in BioPort's manufacturing process[5].

On June 28, 2002, in the wake of the 2001 anthrax attacks and leading up to the 2003 invasion of Iraq, all military personnel were required to get anthrax vaccination[6] (in addition to their other vaccinations of smallpox and other diseases and viruses like Japanese encephalitis, Pneumococcal, Tetanus, among others[7]).

While some military personnel had questions about the safety of the vaccine, it was considered a lawful order at that time, and this made refusing the vaccine at peril of the subordinate, including possible discharge (i.e., losing their job and any benefits depending on the type of discharge). This pressure, at least for the National Guard and Reserve pilots and crewmembers, became a deciding retention factor.[1]

Later that month, the DOD made it policy to include any personnel spending 15 days or more in high anthrax-risk areas, such as the Persian Gulf or the Korean peninsula.[2]

In Dec. of 2003, Judge Emmet G. Sullivan of the United States District Court in Washington ruled that the Department of Defense could not force military personnel to take the vaccine unless through a special order by the president.[3]

In October of 2004, for about 8 days in (October 20-28), anthrax vaccinations were resumed[4], but then an injunction against mandatory vaccination was filed on the basis that the BioPort Anthrax Vaccive Absorbed (AVA) was not proven to work against inhalation anthrax.[5] The ruling held that the mandatory program was illegal. The DoD was now required to either let the individual member choose under an informed consent policy, or allowed the president to bypass this requirement by executive order.[6] For military members who had started the vaccination (which usually takes build-up and booster shots), they tended to continue the vaccination program under informed consent. For those who had a choice, they usually decided against it. [7]. The government stated that they will resume the vaccination program under informed consent in April 2005.

On December 15, 2005, the FDA re-issued a Final Rule & Order[8] on the license status of the anthrax vaccine, clearing the way for mandatory vaccination reinstatement. After reviewing extensive scientific evidence and carefully considering comments from the public, the FDA again determined that the vaccine is licensed for the prevention of anthrax, regardless of the route of exposure.

On Oct. 16, 2006 the military announced intentions to resume vaccinations for select personnel again, but the vaccinations remained voluntary until further guidance by the DoD.[9] The DoD's official resumption status of the program awaited publication of service messages.[10]

On December 13, 2006, a new class-action lawsuit[11], filed on behalf of six unnamed plaintiffs, revived the legal battle over the military’s mandatory anthrax immunization program. According to court documents, the basic premise of the lawsuit is the plaintiffs’ claim that the vaccine is “unapproved for its applied/intended use.” The lawsuit says that “plaintiffs will suffer substantial and irreparable injury if they are forced to take the vaccine,” which the suit says has not been properly approved by the government, despite the Food and Drug Administration issuing its “final rule” on the vaccine on December 15, 2005. The suit also says the Defense Department has failed to follow presidential orders and federal laws that require the government to obtain informed consent before giving an unapproved and experimental vaccine to anyone.

References

  1. ^ "Anthrax Vaccine, GEO's Survey of Guard and Reserve Pilots and Aircrew" United States General Accounting Office Report to Congressional Requesters. Sept. 2002. GAO-02-445.
  2. ^ Pentagon shifts Anthrax vaccine to civilian uses" James Dao with Judith Miller, June 29, 2002.

    Mirrored site: http://query.nytimes.com/gst/fullpage.html?sec=health&res=9C06E7DF1E3EF93AA15755C0A9649C8B63

  3. ^ "Judge: U.S. Can't Force Vaccines" CBS News, Dec. 22, 2003.
  4. ^ "Pentagon Says 200,000 Who Started Anthrax-Shot Regimen Must Continue" Sandra Jontz, Stars and Stripes European Edition, October 20, 2004
  5. ^ [1] DC District Court Permanent Injunction on Summary Judgment, Oct 27, 2004
  6. ^ "Anthrax Vaccinations Halted Again" United Press International, October 28, 2004.
  7. ^ "Troops divided on getting voluntary vaccine shots." Deborah Funk, July 25, 2005 AF Times
  8. ^ Department of Health and Human Services, Food and Drug Administration.
    Docket No. 1980N-0208
    Biological Products; Bacterial Vaccines and Toxoids; Implementation of Efficacy Review; Anthrax Vaccine Adsorbed; Final Order.
    AGENCY: Food and Drug Administration, HHS.
    ACTION: Notice.
  9. ^ Pentagon to Resume Anthrax Inoculations." Lolita C. Baldor, Monday, October 16, 2006.
  10. ^ DoD's official anthrax vaccine immunization program website
  11. ^ "Defense Employees Set For Another Suit to Halt Mandatory Anthrax Shots." Josh White, Wednesday, December 13, 2006; Page A19.

See also

External Links


'"/>


(Date:4/27/2015)... Beckman Coulter is sponsoring a ... the evolution of neural circuitry and swimming behavior of ... mechanisms by which analogous forms of swimming behavior, such ... independently in certain sea slug clades. The webinar is ... 30, 2015 at 8:00am PT. , Sea slugs (Mollusca, ...
(Date:4/27/2015)... April 27, 2015 Sitting or standing for ... and feel tired, and for those whose occupation requires them ... and taxi cab drivers, or to be on their feet ... the discomfort can be more severe and longer lasting. These ... syndrome. Dr. Madaiah Revana of Northeast Houston Vein Center is ...
(Date:4/27/2015)... 27, 2015 FMC Corporation’s Health and ... wide range of market leading ingredients and solutions at ... Geneva, Switzerland. Vitafoods Europe 2015 expects to host 14,000 ... the latest research in such areas as digestive health, ... FMC Health and Nutrition’s booth will feature its world ...
(Date:4/27/2015)... 27, 2015 Telematics Berlin is Europe’s ... suppliers, associations, CE players and the government to discuss ... to the car. This year’s panel on connected car ... the European Commission, is an opportunity to hear and ... a European Automotive Security Standard for years to come. ...
(Date:4/27/2015)... Mirada, CA (PRWEB) April 27, 2015 ... minimally invasive treatments for nail fungi and infections. Onychomycosis, ... to affect up to 10% of adults in the ... fragility, and irregularity in thickness. , Healthpointe’s ... Institute , a branch dedicated to providing quality skincare ...
Breaking Medicine News(10 mins):Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 3Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3Health News:FMC Health and Nutrition to Feature Epax® Brand Omega-3 Ingredients at Vitafoods Europe 2015 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 3Health News:Southern California Healthpointe Clinics Now Treating Nail Fungus 2
... offered to manufacture an antiviral drug for bird flu called ... It has already made Tamiflu in its lab. // , ... popular as Tamiflu has but is cheaper and sometimes a ... Cipla in a press release said:‘‘Zanamivir is the only other ...
... as the first most common cause for death in ... stress echocardiography that can help predict life-threatening heart problems ... conducted among a group of diabetic women aged between ... type of stress test for suspected coronary disease that ...
... an increasing attention is being directed towards cost-effective treatment ... chiropractic care produces significantly // better outcomes when compared ... higher pain relief and satisfaction and lower disability scores ... ,The study has been conducted in the American population ...
... a hand-held scope called VELscope, which has been developed by ... of Dental Craniofacial Research. The devise emits a blue light ... detection of cancerous lesions in the mouth. The VELscope would ... better treatment is achieved when oral cancer is treated in ...
... Livermore National Laboratory are studying the biopolymer structural dynamics ... The new theory on protein folding unfolds the mystery ... leads to diseases and the study is to be ... of Sciences. , ,The researchers used a technique ...
... sclerosis patients in Britain can look forward to some relief, ... for the first time, following approval from the Home Office ... Britain will soon be able to obtain an unlicensed, cannabis-based ... arthritis even though it is yet to be licensed in ...
Cached Medicine News:Health News:Cipla In India Can Manufacture Drug For Bird Flu 2Health News:Cipla In India Can Manufacture Drug For Bird Flu 3Health News:A Simple Test To Detect Heart Disease In Women Can Be Lifesaving 2Health News:Back Pain Can Now Be Cost-Effectively Treated By Chiropractic Care 2Health News:Relief For British MS Patients: Cannabis-Based Oral Spray 2
Other medicine definitionOther Tags